Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide

BACKGROUND: Teriflunomide 14 mg significantly reduced brain volume loss (BVL) and confirmed disability worsening (CDW) compared with placebo in the TEMSO core study. OBJECTIVE: To investigate the relationship between BVL from Baseline to Year 2 in the TEMSO core study and long-term CDW (Year 7) in t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mult Scler
Glavni autori: Sprenger, Till, Kappos, Ludwig, Radue, Ernst-Wilhelm, Gaetano, Laura, Mueller-Lenke, Nicole, Wuerfel, Jens, Poole, Elizabeth M, Cavalier, Steven
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Original Research Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493202/
https://ncbi.nlm.nih.gov/pubmed/31198103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519855722
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items